News and Announcements
John Kelly, Atomo Diagnostics’ Founder and CEO Interviewed on Switzer TV
- Published May 31, 2016 1:52PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
25th May 2016, Swtizter
Atomo Diagnostics is making waves in the diagnostics technology space, and has even attracted the support of the Bill and Melinda Gates Foundation. To look at the company’s innovations, CEO John Kelly joins the show (broadcast on Wednesday 25 May, 2016).
About Atomo Diagnostics
Atomo Diagnostics is a multi-award winning and rapidly growing medical device company that has developed and commercialised AtomoRapid™, the world’s first integrated device for blood based immunoassay rapid diagnostic testing (RDTs) in point of care settings.
Atomo launched its first test on the platform, AtomoRapid HIV, in 2014. Since launch, AtomoRapid tests have quickly established themselves as a “best in class” solution for professional use diagnostic screening.
To watch the interview, please click on the button below.
Company Updates
The Founder’s Void: What Happens the Day After You Sell?
Selling a business can leave a profound sense of emptiness, known as “The Founder’s Void.” This post explores this often-overlooked emotional aftermath and provides strategies for founders to redefine purpose and embrace new opportunities post-sale.
Dubai: The Unsung Bridge for Global Tech Investment and Market Access
In the bustling world of global tech and investment, Dubai is often seen through the lens of its impressive skyline and rapid development. However, beneath the gleaming facade lies a sophisticated ecosystem designed to be a crucial bridge for founders seeking capital and market access, and for investors looking to tap into burgeoning opportunities across […]
Beyond Strategy: Why Your Network Will Define Your Business Exit
Beyond operational readiness, a strong, purpose-built network is crucial for a successful business exit. Learn how an “exit ecosystem” of advisors, capital partners, and fellow founders can define the outcome of your most significant transaction.
Backed By Leading Investment Groups and Family Offices
